LON:CRV Craven House Capital (CRV) Share Forecast, Price & News GBX 0.14 0.00 (0.00%) (As of 09/28/2023 09:00 PM ET) Add Compare Share Share Today's Range 0.15▼ 0.1550-Day Range 0.14▼ 0.1752-Week Range 0.06▼ 0.45VolumeN/AAverage Volume6,598 shsMarket Capitalization£5,597.00P/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsHeadlinesProfileChartCompetitorsHeadlines About Craven House Capital (LON:CRV) StockCraven House Capital Plc operates as an investment company. It primarily focuses on investing in or acquiring a portfolio of companies, partnerships, joint ventures, businesses, or other assets participating in the e-commerce sector. The company was formerly known as AIM Investments plc and changed its name to Craven House Capital Plc in August 2011. Craven House Capital Plc was incorporated in 2004 and is based in London, the United Kingdom.Read More CRV Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CRV Stock News HeadlinesSeptember 25, 2023 | finance.yahoo.comCryptocurrency whales influence market trends with substantial transactionsSeptember 15, 2023 | forbes.comHow To Recognize Human Capital In Your Family BusinessSeptember 29, 2023 | Behind the Markets (Ad)Jeff Bezos Backs "Drug Smuggler" to Fight Alzheimer'sA small, publicly traded biotech is racing to the discovery of a lifetime: Using a Drug Smuggler to Fight Alzheimer's, Parkinson's and Dementia. This radical treatment is so promising, Biogen, Sanofi and Genentech paid $1 billion to license it. Click here to learn more >>>November 22, 2022 | finance.yahoo.comCurve's CRV Token Turns Volatile as Exchange's Balance Hits Record HighSeptember 10, 2022 | investing.comCRV/USD - Curve DAO Token US DollarSeptember 9, 2022 | reuters.comCraven House Capital PLCMarch 18, 2022 | yahoo.comKristen Stewart Reveals Why She Turned Down Opening Death Scene in Scream 4 : 'I Can't Do a Drew'February 25, 2022 | lse.co.ukCraven House Capital Regulatory NewsSeptember 29, 2023 | Behind the Markets (Ad)Jeff Bezos Backs "Drug Smuggler" to Fight Alzheimer'sA small, publicly traded biotech is racing to the discovery of a lifetime: Using a Drug Smuggler to Fight Alzheimer's, Parkinson's and Dementia. This radical treatment is so promising, Biogen, Sanofi and Genentech paid $1 billion to license it. Click here to learn more >>>November 30, 2021 | marketwatch.comCraven House Capital FY 2021 Loss NarrowedAugust 16, 2021 | msn.comPlymouth shooting - news: Jake Davison gun licence returned weeks before mass murder as vigil held for victimsJuly 20, 2021 | msn.comWhy Is It So Hard for Moderate Dems to ‘Do Popular Things’?July 19, 2021 | abcnews.go.comSenate Democrats take voting rights push to GeorgiaJuly 15, 2021 | msn.comGannett Community Thrives grants can aid people, pets and a historic structure in New BernJuly 15, 2021 | dailymail.co.ukFugitive Texas Dems take their kids to meet senators at the Capitol on their second day on the runJuly 15, 2021 | dailymail.co.ukTexas Speaker calls on state Democrats who fled to Washington to forfeit their payJuly 14, 2021 | dailymail.co.ukBiden calls GOP voting bills 'odious and vicious' and are 'the most significant threat to democracy since the Civil War' in speech attacking the Supreme Court, Trump's 'Big Lie ...July 14, 2021 | dailymail.co.ukTexas GOP Gov. Greg Abbott accuses Biden of spreading 'misinformation' on voting rights because his state's election bills will 'make it EASIER' to cast a ballot by expanding ...July 14, 2021 | lse.co.ukCraven House Capital Share ChatJuly 10, 2021 | msn.comFirst impressions count: where to find London’s loveliest lobbies and how to get the lookJuly 6, 2021 | msn.comThe actual options now at Liverpool star's feet as Cardiff City and Swansea City stances set out and the risk that would top the lotJuly 5, 2021 | law360.comAluminum Importer Sues Over Duplicative Evasion ProbesJuly 4, 2021 | wsj.comJuly 4th Puts Focus on Surging Sales of Fireworks, and a Severe TollJuly 3, 2021 | news.yahoo.comThe Podcasting Feud Over the Iraq War’s LegacyJuly 1, 2021 | proactiveinvestors.com"Build your own Facebook" web technology firm Tribe raises US$7.5mln in funding roundJune 25, 2021 | yahoo.comThey Seemed Like Democratic Activists. They Were Secretly Conservative Spies.See More Headlines Receive CRV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Craven House Capital and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON Industry Asset Management Sub-IndustryN/A SectorFinancial Services Current SymbolLON:CRV CUSIPN/A CIKN/A Webwww.cravenhousecapital.com Phone44 2032 868130FaxN/AEmployees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on Equity-4.50% Return on Assets-1.75% Debt Debt-to-Equity Ratio24.11 Current Ratio0.58 Quick Ratio0.01 Sales & Book Value Annual Sales£-1,657,000.00 Price / Sales0.00 Cash FlowGBX 0.10 per share Price / Cash Flow1.40 Book ValueGBX 133 per share Price / Book0.00Miscellaneous Outstanding Shares3,860,000Free FloatN/AMarket Cap£5,597.00 OptionableNot Optionable Beta0.28 10 Best Stocks to Own in 2023Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2023 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Brian WintersGen. CounselMs. Tamra SpinkCompany Sec.Key CompetitorsMyanmar Investments InternationalLON:MILUIL FinanceLON:UTLIAlternative Liquidity FundLON:ALFAfrica Opportunity FundLON:AOFNB Distressed Debt Investment FundLON:NBDDView All Competitors CRV Stock - Frequently Asked Questions How have CRV shares performed in 2023? Craven House Capital's stock was trading at GBX 0.09 at the beginning of the year. Since then, CRV stock has increased by 70.6% and is now trading at GBX 0.15. View the best growth stocks for 2023 here. What is Craven House Capital's stock symbol? Craven House Capital trades on the London Stock Exchange (LON) under the ticker symbol "CRV." How do I buy shares of Craven House Capital? Shares of CRV stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is Craven House Capital's stock price today? One share of CRV stock can currently be purchased for approximately GBX 0.15. How much money does Craven House Capital make? Craven House Capital (LON:CRV) has a market capitalization of £5,597.00 and generates £-1,657,000.00 in revenue each year. How can I contact Craven House Capital? Craven House Capital's mailing address is International House, 776-778 Barking Road, London E13 9PJ, United Kingdom. The official website for the company is www.cravenhousecapital.com. The company can be reached via phone at 44 2032 868130. This page (LON:CRV) was last updated on 9/29/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Craven House Capital Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.